Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jukka Westerbacka

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Dietary fat content modifies liver fat in overweight nondiabetic subjectsJukka Westerbacka, Katriina Lammi, Anna-Maija Häkkinen, et al.
Atherosclerosis|February 28, 2012
Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacityMartin Adiels, Niina Matikainen, Jukka Westerbacka, et al.
Diabetology & Metabolic Syndrome|December 20, 2021
A review of reusable insulin pens and features of TouStar-a new reusable pen with a dedicated cartridgeRobert Veasey, Carolin A Ruf, Dmitri Bogatirsky, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 14, 2008
Insulin regulation of MCP-1 in human adipose tissue of obese and lean womenJukka Westerbacka, Anja Cornér, Maria Kolak, et al.
Diabetes|August 21, 2007
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjectsJukka Westerbacka, Maria Kolak, Tuula Kiviluoto, et al.
Endocrinology, Diabetes & Metabolism|November 22, 2021
Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world studySean D Sullivan, Nick Freemantle, Rishab A Gupta, et al.
Diabetes|October 28, 2008
Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liverAnna Kotronen, Tuulikki Seppänen-Laakso, Jukka Westerbacka, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal menAnneli Seppälä-Lindroos, Satu Vehkavaara, Anna-Maija Häkkinen, et al.
Obesity (Silver Spring, Md.)|October 3, 2009
Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serumAnna Kotronen, Tuulikki Seppänen-Laakso, Jukka Westerbacka, et al.
Diabetes, Obesity & Metabolism|March 9, 2021
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trialGeremia B Bolli, Alice Cheng, Bernard Charbonnel, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Dietary fat content modifies liver fat in overweight nondiabetic subjectsJukka Westerbacka, Katriina Lammi, Anna-Maija Häkkinen, et al.
Atherosclerosis|February 28, 2012
Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacityMartin Adiels, Niina Matikainen, Jukka Westerbacka, et al.
Diabetology & Metabolic Syndrome|December 20, 2021
A review of reusable insulin pens and features of TouStar-a new reusable pen with a dedicated cartridgeRobert Veasey, Carolin A Ruf, Dmitri Bogatirsky, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 14, 2008
Insulin regulation of MCP-1 in human adipose tissue of obese and lean womenJukka Westerbacka, Anja Cornér, Maria Kolak, et al.
Diabetes|August 21, 2007
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjectsJukka Westerbacka, Maria Kolak, Tuula Kiviluoto, et al.
Endocrinology, Diabetes & Metabolism|November 22, 2021
Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world studySean D Sullivan, Nick Freemantle, Rishab A Gupta, et al.
Diabetes|October 28, 2008
Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liverAnna Kotronen, Tuulikki Seppänen-Laakso, Jukka Westerbacka, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal menAnneli Seppälä-Lindroos, Satu Vehkavaara, Anna-Maija Häkkinen, et al.
Obesity (Silver Spring, Md.)|October 3, 2009
Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serumAnna Kotronen, Tuulikki Seppänen-Laakso, Jukka Westerbacka, et al.
Diabetes, Obesity & Metabolism|March 9, 2021
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trialGeremia B Bolli, Alice Cheng, Bernard Charbonnel, et al.
Pageof 6